International Congress London 2016

Saturday, 03.09.2016
Sunday, 04.09.2016
Monday, 05.09.2016
Tuesday, 06.09.2016
Wednesday, 07.09.2016

 

Sponsored symposia:

Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2016; 48: Suppl. 60, abstract number.


Community-acquired pneumonia: update on prognostic factors and therapeutic strategies

Oral Presentation
Chairs: Antoni Torres Marti (Barcelona, Spain)
LATE-BREAKING ABSTRACT: Intravenous infusion of Chinese medicine xuebijing significantly improved clinical outcome in severe pneumonia patients in a multiple center randomized controlled clinical trials
Yuanlin Song (Shanghai, China), Yuanlin Song, Chen Yao, Hongcai Shang, Xiaoqing Yao, Chunxue Bai
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Do school holidays affect adult pneumococcal community acquired pneumonia incidence?
Priya Daniel (Nottingham, United Kingdom), Priya Daniel, Chamira Rodrigo, Thomas Bewick, Sonia Greenwood, Tricia Mckeever, Carmen Sheppard, Mary Slack, Wei Shen Lim
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Cardiac troponin T in predicting mortality after hospitalisation for community-acquired pneumonia
Stefan Vestjens (Nieuwegein, Netherlands), Stefan Vestjens, Simone Spoorenberg, Ger Rijkers, Jan Grutters, Jurriën Ten Berg, Ewoudt van de Garde, Willem Jan Bos
Congress or journal article abstract
Congress or journal article abstract
Biomarkers and cardiovascular events in community-acquired pneumonia
Raúl Méndez (Valencia, Spain), Raúl Méndez, Irene Aldás, Isabel Amara-Elori, Alexandra Gimeno, Tomás Posadas, Soledad Reyes, Marta Suescun, Ricardo Alonso, Rosario Menéndez
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Survival benefit of beta-lactam plus macrolide combined therapy versus beta-lactam plus quinolones in hospitalized community-acquired pneumonia
Francisco Sanz Herrero (Quart de Poblet (Valencia), Spain), Francisco Sanz Herrero, Estrella Fernández-Fabrellas, Eusebi Chiner, María Luisa Briones, Ruben Lera, María Carmen Aguar, Ángela Cervera, José Blanquer
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia
Adrian Ceccato (Ituzaingo, Argentina), Adrian Ceccato, Miquel Ferrer, Albert Gabarrus, Oriol Sibilla, Eva Polverino, Catia Cilloniz, Carlos Agusti, Francisca Lopez, Michael Niederman, Antoni Torres
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia
Eric Mortensen (Dallas, United States of America), Eric Mortensen, Antonio Anzueto
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Non-steroidal anti-inflammatory drugs may worsen the course of community-acquired pneumonia : A cohort study
Damien Basille (Amiens, France), Damien Basille, Charlotte Trouve, Nathalie Plouvier, Claire Andrejak, Vincent Jounieaux
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation